Avagenesis Corp. announced the appointment of Dr. Richard Cook, MD, MSc., FRCSC, as Chief Medical Officer. Dr. Cook is a Clinical Associate Professor of Surgery with the Division of Cardiovascular Surgery at the University of British Columbia and is an expert in complex mitral valve repair and minimally-invasive and robotic cardiac surgery.

With Dr. Cook's appointment and the transition of Avagenesis to a clinical stage company, Avagenesis has accepted the resignation of Chris Chang, Ph.D., Chief Scientific Officer, effective immediately.